Crypto
Ripple Community Demands Coinbase to Add XRP Back to Its Offering
It’s safe to assume that resourceful U.S. investors have found ways to move their trading of XRP offshore over the past two years. But it would be a strong pro-Ripple signal if Coinbase in the U.S. rethinks and adds XRP back to its offering, even if a verdict in the mammoth SEC v. Ripple trial is still pending. However, this probably remains wishful thinking.
In the U.S., pressure is growing on crypto exchange Coinbase to relist Ripple (XRP). The argument: the SEC, which is suing Ripple, is not responsible for secondary markets. However, Coinbase remained cautious.
Ripple (XRP) has shone over the past few weeks with a small rally and turned over the past month a good 30 percent into the plus. But those who wanted to profit from the trend as investors in the USA were looking down the tube.
Since the U.S. Securities and Exchange Commission sued Ripple over XRP in December 2020, the altcoin is no longer represented on legal crypto exchanges in North America. U.S. market leader Coinbase listed XRP shortly before the end of 2020 and explicitly referred to the lawsuit between the SEC and Ripple and associated risks in its reasoning at the time. But since February, a campaign has been underway to get Coinbase to relist XRP and has good arguments on its side.
Read more about Ripple and find the most important business headlines of the day with the born2Invest mobile app.
Now Coinbase’s chief legal officer, Paul Grewal, has spoken out on Twitter about the XRP case, and Ripple supporters see it as an encouraging sign
That’s because Grewal agrees with crypto lawyer John Deaton, who is certain that XRP or other cryptocurrencies do not fall under SEC regulation at all when trading on secondary markets. Deaton had achieved legal clarification here in the LBRY case in an appeal for the altcoin: while a licensing requirement (by the SEC) was affirmed for the initial sale of LBRY, the court saw the situation differently on secondary markets and judged trading there to be permissible even without the SEC’s okay.
Lawyer Grewal from Coinbase now adopts Deaton’s argumentation and also writes that there is no “investment contract” when trading cryptocurrencies on secondary markets such as crypto exchanges. Both a contract within the meaning of the law is not entered into and no investment subject to authorization is made. The Ripple community takes this tweet from Grewla as an opportunity to energetically call on Grewal and Coinbase to list XRP again – because the legal risk is manageable since the LBRY case.
Conclusion: US investors want XRP back on the legal market
It’s safe to assume that resourceful U.S. investors have found ways to move their trading of XRP offshore over the past two years. But it would be a strong pro-Ripple signal if Coinbase in the U.S. rethinks and adds XRP back to its offering, even if a verdict in the mammoth SEC v. Ripple trial is still pending.
However, this probably remains wishful thinking: In a video interview a few weeks ago, Rewal had still said that Coinbase would only re-evaluate its handling of XRP once the Ripple ruling was available.
__
(Featured image by Rūdolfs Klintsons via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech1 week ago
Córdoba Biotech Started the Process to Select 20 New Startups
-
Impact Investing33 minutes ago
Greenhouse Emissions of the Spanish Healthcare Sector Increased by 1.6% in 2023
-
Biotech2 weeks ago
Eli Lilly Misses Wall Street’s Revenue Expectations in Q3
-
Africa6 days ago
The Moroccan Tourism Sector Continues to Break Records